ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,203,000 | +2382.4% | 371,306 | +798.8% | 0.49% | +1941.7% |
| Q2 2018 | $693,000 | -44.3% | 41,310 | -45.9% | 0.02% | -40.0% |
| Q1 2018 | $1,245,000 | +659.1% | 76,307 | +494.6% | 0.04% | +900.0% |
| Q4 2017 | $164,000 | -82.3% | 12,834 | -82.9% | 0.00% | -83.3% |
| Q3 2017 | $925,000 | +50.7% | 75,184 | +2.5% | 0.02% | +26.3% |
| Q2 2017 | $614,000 | -32.6% | 73,373 | -45.6% | 0.02% | -9.5% |
| Q3 2016 | $911,000 | +101.1% | 135,000 | +25.8% | 0.02% | +61.5% |
| Q4 2015 | $453,000 | +771.2% | 107,347 | +833.5% | 0.01% | +550.0% |
| Q3 2015 | $52,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |